← Back to Clinical Trials
Recruiting NCT07502391

NCT07502391 Sex-Dependent Risk of Postoperative Delirium and Mediating Effects of Family Visits

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07502391
Status Recruiting
Phase
Sponsor Julian Rössler
Condition Postoperative Delirium (POD)
Study Type OBSERVATIONAL
Enrollment 471 participants
Start Date 2026-05-05
Primary Completion 2028-12-31

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 471 participants in total. It began in 2026-05-05 with a primary completion date of 2028-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Postoperative delirium is a common and serious complication after surgery, affecting 10-40% of older patients undergoing non-cardiac procedures. It is characterized by sudden changes in attention, awareness, and thinking that fluctuate throughout the day. Delirium is associated with longer hospital stays, higher mortality, worse long-term brain function, and substantially increased healthcare costs. While several risk factors are known, it remains unclear whether a patient's sex independently influences the risk of developing postoperative delirium, as existing studies have produced conflicting results and were often not designed to specifically examine sex differences.Family visitation is a promising non-drug approach to preventing delirium. Studies in intensive care patients have shown that those who receive family visits have a significantly lower risk of developing delirium. However, it is unknown whether men and women receive different amounts of family visits after surgery, and whether any such difference could help explain sex-based disparities in delirium risk. Given that traditional gender roles in caregiving persist, women - who often serve as primary caregivers in their families - may receive fewer visits when they themselves become patients.This prospective observational study led by the University of Zurich will enroll 471 patients aged 65 years or older undergoing non-cardiac surgery lasting at least 2 hours under general or spinal anesthesia. The primary aim is to determine whether female patients have a higher risk of developing postoperative delirium within three days after surgery compared to male patients. Delirium will be assessed twice daily using the 4 A's Test (4AT), a validated and standardized screening tool. The secondary aim is to evaluate whether female patients receive fewer family visits than male patients and whether any difference in visitation mediates the sex-dependent delirium risk. Family visits will be recorded using an anonymous sign-in sheet placed in the patient's room. The study does not involve any experimental interventions; all patients receive standard clinical care. Participation is voluntary, and withdrawal is possible at any time without affecting medical treatment.

Eligibility Criteria

Inclusion Criteria: * Informed consent as documented by signature; * ≥65 years of age; * Scheduled non-cardiac surgery with expected surgery duration ≥ 2 hours; * Under either general or spinal anesthesia. Exclusion Criteria: * Known drug or alcohol abuse; * Requirement for postoperative ventilation; * Current participation in another study with an investigational drug; * Inability to complete the study assessments.

Frequently Asked Questions

Who can join the NCT07502391 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, studying Postoperative Delirium (POD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07502391 currently recruiting?

Yes, NCT07502391 is actively recruiting participants. Visit ClinicalTrials.gov or contact Julian Rössler to inquire about joining.

Where is the NCT07502391 trial being conducted?

This trial is being conducted at Zurich, Switzerland.

Who is sponsoring the NCT07502391 clinical trial?

NCT07502391 is sponsored by Julian Rössler. The trial plans to enroll 471 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology